Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by "Лактина" ОодfiledCritical"Лактина" Оод
Priority to BG108615ApriorityCriticalpatent/BG65614B1/en
Publication of BG108615ApublicationCriticalpatent/BG108615A/en
Publication of BG65614B1publicationCriticalpatent/BG65614B1/en
Medicines Containing Material From Animals Or Micro-Organisms
(AREA)
Abstract
The invention relates to a synbiotic (probiotic and prebiotic) for human purposes which is administered as additive to the food of people for well intended favorable effect on their health. The synbiotic comprises a mixture of monocultures Lactobacillus acidophilus N 180, N NBIMCC 8242, Lactobacillus helveticus N 173, N NBIMCC 8268, Lactobacillus helveticus N 179, Lactobacillus delbrueckii subsp.Lactis N 182, NBIMCC 8250, Lactobacillus debrueckii subsp. Bulgaricus N 186, N NBIMCC 8243, Lactobacillus debrueckii subsp. Bulgaricus N 190, N NBIMCC 8247, Streptococcus thermophilus N 205, N NBIMCC8253, Bifidobacterium bifidum N PB-b1, N NBIMCC 8328 and Bifidobacterium longum NPB-b3, N NBIMCC 8329. The newly isolated strains of lactic acid bacteria and bifidobacteria individually and together have the highest probiotic effect, have good survival in acid medium, separate considerable amount of bacteriocines, which inhibit the total amount of the conditionally pathogenic microorganisms in the gastrointestinal tract. The components of the synbiotic mutually ensure optimum conditions for retention in the mucous membrane and the development and propagation of cultures. Its composition is rich in indispensable amino acids and biologically active substances, which promote the general health status of the organism.
COMPOSITION BASED ON PROBIOTIC BACTERIA AND ITS APPLICATION IN PREVENTION AND / OR TREATMENT OF RESPIRATORY PATHOLOGIES AND / OR INFECTIONS AND IN IMPROVING THE INTESTINAL FUNCTION
Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
CONSORTIUM bifidobacteria Bifidobacterium bifidum 791-MB, Bifidobacterium longum in 379M- MB, BIFIDOBACTERIUM ADOLESCENTIS D 7513-MB, BIFIDOBACTERIUM INFANTIS 73-15-MB, BIFIDOBACTERIUM BREVE 79-119-MB, used to prepare fermented milk, unfermented PRODUCTS, biologically active ADDITIVES, BIFIDIFICATION-CONTAINING PREPARATIONS, COSMETIC AND HYGIENIC MEANS
NON-REPLICATING PROBIOTIC BACTERIA AND PREVENTION OR THERAPY OF INFECTIONS IN ORDER TO REDUCE THE MISSION OF VISITS OF SCHOOL OR INSTITUTIONS OF DAY CARE FOR CHILDREN